• News
  • BioTech

Purdue abuse-resistant pill may push Zogenix drug off market

Purdue Pharma LP plans to apply for regulatory approval of a tamper-resistant competitor to Zogenix Inc.’s (Nasdaq: ZGNX) powerful pain pill, a move that could get its rival’s drug pulled from the market by U.S. regulators.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!